Johnson & Johnson (NYSE:JNJ) and Medtronic (NYSE:MDT) were named in the Boston Consulting Group’s list of the 50 most innovative companies this year at the 20 and 42 spot, respectively. Apple (NSDQ:AAPL) and Google (NSDQ:GOOG) took the top 2 spots on the list. Other notable entries were Gilead at number 8, Bayer‘s (ETR:BAYN) at 11, Biogen (NSDQ:BIIB) at […]
Hitachi wins FDA 510(k) for Supria CT system
Hitachi (NYSE:HIT) said yesterday it won FDA 510(k) clearance for its Supria 16-slice CT system imaging platform. The new device features a compact design and a Smart-Dose compliant dose saving system that can reduce the amount of radiation for the patient undergoing imaging, the company said. “Supria demonstrates Hitachi’s continuing commitment to provide superior product value […]
NICO & Hitachi collab on ultrasound brain probe
Neurological device maker NICO and Hitachi (NYSE:HIT) said they are collaborating to create an ultrasound probe to aid in brain tumor operations using Nico’s BrainPath device. Hitachi’s Aloka ultrasound probe, which is still being developed, will be usable with Nico’s BrainPath device to allow operators better visualization of the location, size, and proximity of vessels during […]
Siemens lands $1.8B Pentagon contract extension
Siemens Medical Systems (NYSE:SI) won a $1.79 billion extension on its contract to provide radiology systems to the U.S. Defense Dept.
The Pentagon said it pulled the trigger on its 5th option on the 1-year deal, which has another 2 option years ahead.
Hitachi, Omega Medical land $28M in DoD radiology deals
FDA OKs Hitachi Medical CT scanner
Hitachi (NYSE:HIT) said it won 510(k) clearance from the FDA for its Scenaria Advanced 128 CT scanner, the latest in its line of scalable CT scanners.
Hitachi Medical Systems America said the latest iteration of the Scenaria Advanced includes new low-dose technology designed to reduce patients’ exposure to X-ray radiation.
Device tax spurs Hill-Rom to lay off 200 | Wall Street Beat
Hill-Rom Holdings (NYSE:HRC) said it will lay off about 3% of its workforce, or roughly 200 workers, as it maneuvers to confront the medical device tax set to go into effect next year.
St. Jude lands FDA win for 2 next-gen cardiac ablation catheters | Regulatory Roundup
St. Jude Medical Inc. (NYSE:STJ) won pre-market approval for 2 next-generation cardiac ablation systems this month, the Therapy Cool Path Duo and Safire Blu Duo catheters.
Both ablation systems use radiofrequency energy to freeze small areas of faulty cardiac tissue in patients with typical trial flutter, a type of arrhythmia in which patients experience abnormal heart rhythms or an abnormally fast heartbeat in the upper chambers of the heart.
